 Pfizer and BioNTech started testing a combined flu and Covid vaccine on Thursday, helping BNTX stock pare earlier Moderna-inspired losses. The post BioNTech Shares Up On Hope For Combined Flu, Covid Shot appeared first on Investors Business Daily. 